nitrites has been researched along with kynuramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hardeland, R; Leon, J; Mayo, JC; Reiter, RJ; Rodriguez, C; Sainz, RM; Tan, DX | 1 |
| Backhaus, C; Fadavi, A; Hardeland, R | 1 |
| Acuña-Castroviejo, D; Camacho, E; Carrión, MD; Entrena, A; Escames, G; Espinosa, A; Gallo, MA; López, A; López, LC; Tapias, V | 1 |
3 other study(ies) available for nitrites and kynuramine
| Article | Year |
|---|---|
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Indoles; Kynuramine; Lipopolysaccharides; Macrophage Activation; Macrophages; Melatonin; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Superoxides | 2005 |
Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine.
Topics: Hydrogen-Ion Concentration; Kinetics; Kynuramine; Melatonin; Nitric Oxide Donors; Nitrites; Nitro Compounds; Nitrogen Oxides; Oxidation-Reduction; Reactive Nitrogen Species | 2007 |
Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
Topics: Animals; Calcium; Corpus Striatum; Cytosol; Electron Transport Complex I; Enzyme Induction; Kynuramine; Male; Melatonin; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; MPTP Poisoning; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Parkinsonian Disorders; Substantia Nigra | 2009 |